his associates undoubtedly demonstrated that intravenous hydralazine produces beneficial hemodynamic effects in hypertensive patients with evidence of congestive heart failure and I apologize for our oversight. The purpose of our study, however, was to evaluate the hemodynamic effects of long-term use of oral hydralazine in normotensive patients with chronic refractory heart failurea different subset of patients than these studies by Dr.
Mitral Valve Prolapse and Coronary Artery Spasm
To the Editor:
A recent article by Chesler et al. 1 (54: 203, 1976 ) postulated that spasm of normal coronary arteries was responsible for acute myocardial infarction in four cases with the billowing mitral leaflet syndrome. They postulated also2 that the spasm was a reflex response to the prolapsing mitral leaflet.
Recently, we have studied a fifty-five-year-old lady who was admitted because of prolonged episodes of chest pain, to rule out coronary artery disease. Cardiac catheterization and cineangiography demonstrated normal intracardiac pressures but a definite prolapse of the posterior leaflet of the mitral valve ( fig. 1 ). Selective coronary arteriography revealed normal left system, spasm of a prolonged segment of the right coronary artery proximally ( fig. 2 ) which resolved in subsequent injections ( fig. 3 ). Echocardiography showed prolapse pattern of the posterior mitral valve leaflet. Midsystolic click and late systolic murmur were present on physical examination.
Although our case did not have documented acute myocardial infarction, it adds some information to the theory suggested by Although it is possible that the presence of mitral valve prolapse and coronary artery spasm was coincidental, we think that the case we studied adds some evidence to Chesler's theory and we agree that this hypothesis warrants further examination.
Texas Tech School of Medicine Amarillo, Texas To the Editor:
We read with considerable interest the article by Synhorst et al. on the hemodynamic effects of vasodilator agents in dogs with experimental ventricular septal defects.' The authors suggest, on the basis of their experiments, a therapeutic use of vasodilator agents in the treatment of congestive heart failure in patients with large leftto-right shunts at the ventricular level.
The article is based on the assumption that, after the administration of vasodilator agents such as phentolamine, phenoxybenzamine, and isoproterenol, no change in pulmonary vascular resistance occurs or, at least, a fall less than that taking place in systemic vascular resistance. As a consequence, a decline in the ratio Qp/Qs ensues. This is the case with mature animals having less prominent pulmonary vascular musculature than in early life; it is questionable, however, whether this is also true for patients with large congenital ventricular septal defects, in which an increased pulmonary vasomotor tone can very often be present, In this situation, the administration of vasodilator agents (both beta-stimulating, such as isoproterenol, and alpha-blocking, such as tolazoline), considerably decreases the pulmonary vasomotor tone and, as a consequence, an increased left-to-right shunt occurs.
As a matter of fact, it is well known that vasodilator agents are used to test the state of the pulmonary vascular tree in cases of elevated pulmonary vascular resistance2 (in our laboratory we routinely use metaproterenol).
We wonder, therefore, whether the therapeutic use of the drugs suggested by Synhorst can be considered safe in patients with large congenital ventricular septal defects. Our objection is that, in these patients (who are very likely to have an increased pulmonary vasomotor tone) the left-to-right shunt will increase instead of decreasing, with negative hemodynamic consequences on the left ventricle.
The only natural condition resembling that created by the authors could be an acute myocardial infarction with rupture of the interventricular septum. Here a torrential left-to-right shunt occurs because of the low pulmonary vascular resistance; but in this condition, of course, vasodilator agents must be used in relation to the general situation.
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